Syndax Pharmaceuticals Inc (SNDX) Smart Money Holdings (13F, Q2 2026)

SNDX ranks #2576 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

SNDX is a top-conviction position for Elmind Capital, LP — at 10.2% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in SNDX belongs to BlackRock, Inc., but the position matters far more to Elmind Capital, LP, who has 10.2% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

California State Teachers Retirement System has added to its SNDX position for two straight quarters, increasing it by $91.8M to reach $93.5M today.

Jane Street Group, LLC has trimmed its SNDX position for two straight quarters, cutting it by $17.0M while still holding $430.6K.

SNDX is up 3.4% today, and institutions have been net buyers of $361.0M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

SNDX reported a net loss of $220.8M over the trailing twelve months.

• Not yet profitable — net loss of $220.8M over the trailing twelve months
• Revenue grew 222.7% year over year
• Net income improved year over year, from -$335.0M to -$220.8M
• Operating cash flow was negative, using $323.0M in cash
• Current ratio of 4.40x — enough short-term assets to cover short-term liabilities
• Liabilities run 7.20x equity — a highly leveraged balance sheet worth noting